Riastap (Fibrinogen) Vial Amp 1G Skip to content
Local deliveries in La Paz, Los Cabos, Querétaro, and San Miguel de Allende. National shipping to all of Mexico.
Local deliveries in La Paz, Los Cabos, Querétaro, and San Miguel de Allende. National shipping throughout Mexico

Riastap (Fibrinogen) Vial Amp 1G

Sold out
Original price $ 15,568.50
Original price $ 15,568.50 - Original price $ 15,568.50
Original price $ 15,568.50
Current price $ 14,011.65
$ 14,011.65 - $ 14,011.65
Current price $ 14,011.65

La venta de este medicamento requiere receta médica. Su dispensación está sujeta a la validación de la receta y al cumplimiento de la normativa sanitaria vigente. La información contenida en este sitio tiene fines exclusivamente informativos y comerciales, incluyendo la descripción y el precio del producto, y no sustituye la valoración, diagnóstico o prescripción de un profesional de la salud.

SKU 12157
Availability:
Out of stock
Notify me when they have inventory available

¿Necesitas este producto u otro medicamento?

Este producto está agotado por el momento. Nuestros asesores farmacéuticos pueden ayudarte a conseguirlo o encontrar la mejor alternativa para tu tratamiento.

Contáctanos por WhatsApp

Category

Hospital-use medications

Line

Hemostatic medications

Brand

Riastap

Molecule

Fibrinogen

Presentation

1G Vial

Laboratory

Csl Behring

Indications

Riastap is indicated for the treatment of patients with fibrinogen deficiency, including those with afibrinogenemia or hypofibrinogenemia. This medication is used in clinical situations requiring the restoration of adequate fibrinogen levels for proper blood clotting. It is recommended in cases of severe hemorrhages where fibrinogen levels are critically low and in surgical or invasive procedures in patients with coagulation disorders. Additionally, Riastap can be used to prevent or treat hemorrhages in patients with hematological disorders related to fibrinogen deficiency.

Composition

Each Riastap vial contains a lyophilized powder of human plasma-derived fibrinogen, which is reconstituted with a sterile solvent before administration. The concentration of fibrinogen, as well as the excipients used, are specified in the product leaflet.

Contraindications

Riastap is contraindicated in patients with a history of hypersensitivity to any of its components or to human plasma-derived products. Its use should also be avoided in patients with coagulopathies unrelated to fibrinogen deficiency.

Precautions

It is important to monitor fibrinogen levels in patients during treatment. Caution should be exercised in those with a history of thrombosis or cardiovascular diseases, as fibrinogen administration may increase the risk of thrombotic events. Regular coagulation tests are recommended, and the dosage should be adjusted as needed.

Storage

Riastap should be stored in a cool, dry place, at a temperature not exceeding 25°C. Keep out of reach of children. Do not use after the expiry date indicated on the package.

Consult your doctor

Shipping

  1. Free home delivery by local branches on orders over $1000. Otherwise, a $50 fee will be added in the cities of Querétaro and La Paz, BCS, and $150 in San José del Cabo and Cabo San Lucas, BCS.
  2. FREE national shipping via ground on orders over $1,500.00. Otherwise, a fee of $170.00 MXN (One hundred seventy Mexican pesos) will be added for a standard package with dimensions up to 20cm x 20cm x 20cm and 1kg in weight, and $290.00 MXN (Two hundred ninety Mexican pesos) for packages exceeding the aforementioned dimensions or weight.
  3. In case of oversized items, the corresponding fee will apply according to the parcel service.
  4. Orders received after 2:00 PM will be shipped the next day.
  5. For more details, please consult our shipping policy.

Payment and Security

Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.

Category

Hospital-use medications

Line

Hemostatic medications

Brand

Riastap

Molecule

Fibrinogen

Presentation

1G Vial

Laboratory

Csl Behring

Indications

Riastap is indicated for the treatment of patients with fibrinogen deficiency, including those with afibrinogenemia or hypofibrinogenemia. This medication is used in clinical situations requiring the restoration of adequate fibrinogen levels for proper blood clotting. It is recommended in cases of severe hemorrhages where fibrinogen levels are critically low and in surgical or invasive procedures in patients with coagulation disorders. Additionally, Riastap can be used to prevent or treat hemorrhages in patients with hematological disorders related to fibrinogen deficiency.

Composition

Each Riastap vial contains a lyophilized powder of human plasma-derived fibrinogen, which is reconstituted with a sterile solvent before administration. The concentration of fibrinogen, as well as the excipients used, are specified in the product leaflet.

Contraindications

Riastap is contraindicated in patients with a history of hypersensitivity to any of its components or to human plasma-derived products. Its use should also be avoided in patients with coagulopathies unrelated to fibrinogen deficiency.

Precautions

It is important to monitor fibrinogen levels in patients during treatment. Caution should be exercised in those with a history of thrombosis or cardiovascular diseases, as fibrinogen administration may increase the risk of thrombotic events. Regular coagulation tests are recommended, and the dosage should be adjusted as needed.

Storage

Riastap should be stored in a cool, dry place, at a temperature not exceeding 25°C. Keep out of reach of children. Do not use after the expiry date indicated on the package.

Consult your doctor